Alwhaibi, A.; Alenazi, M.A.; Alnofaie, S.D.; Aldekhail, A.M.; Alanazi, R.J.; Alghadeer, S.; Alghamdi, A.A.; Alanazi, S.A.
Real-World Comparison of Health-Related Quality of Life Associated with Use of Immune-Checkpoint Inhibitors in Oncology Patients. J. Clin. Med. 2024, 13, 4918.
https://doi.org/10.3390/jcm13164918
AMA Style
Alwhaibi A, Alenazi MA, Alnofaie SD, Aldekhail AM, Alanazi RJ, Alghadeer S, Alghamdi AA, Alanazi SA.
Real-World Comparison of Health-Related Quality of Life Associated with Use of Immune-Checkpoint Inhibitors in Oncology Patients. Journal of Clinical Medicine. 2024; 13(16):4918.
https://doi.org/10.3390/jcm13164918
Chicago/Turabian Style
Alwhaibi, Abdulrahman, Miteb A. Alenazi, Saad D. Alnofaie, Abdullah M. Aldekhail, Rakan J. Alanazi, Sultan Alghadeer, Abdulrhman A. Alghamdi, and Saleh A. Alanazi.
2024. "Real-World Comparison of Health-Related Quality of Life Associated with Use of Immune-Checkpoint Inhibitors in Oncology Patients" Journal of Clinical Medicine 13, no. 16: 4918.
https://doi.org/10.3390/jcm13164918
APA Style
Alwhaibi, A., Alenazi, M. A., Alnofaie, S. D., Aldekhail, A. M., Alanazi, R. J., Alghadeer, S., Alghamdi, A. A., & Alanazi, S. A.
(2024). Real-World Comparison of Health-Related Quality of Life Associated with Use of Immune-Checkpoint Inhibitors in Oncology Patients. Journal of Clinical Medicine, 13(16), 4918.
https://doi.org/10.3390/jcm13164918